NCT05580549View on ClinicalTrials.gov

Prevalence of Hazardous Alcohol Use in a Population With Hypertension in Primary Care

UnknownOBSERVATIONAL
Enrollment

270

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

June 30, 2023

Study Completion Date

December 31, 2023

Conditions
HypertensionAlcohol DrinkingAlcohol Use, Unspecified
Interventions
DIAGNOSTIC_TEST

Alcohol biomarker Phosphatidylethanol (PEth)

The prevalence of hazardous alcohol use will be mapped through the biomarker PEth and the questionnaire AUDIT.

Trial Locations (1)

10431

RECRUITING

Region Stockholm, Stockholm

Sponsors

Collaborators (1)

Forte
All Listed Sponsors
collaborator

Karolinska Institutet

OTHER

collaborator

Forte

INDUSTRY

collaborator

Sophiahemmet University

OTHER

lead

Region Stockholm

OTHER_GOV

NCT05580549 - Prevalence of Hazardous Alcohol Use in a Population With Hypertension in Primary Care | Biotech Hunter | Biotech Hunter